Loading company…
Thederma develops drugs for immune-mediated and autoimmune inflammatory diseases.
Thederma focuses on therapies related to the AhR target, including potential treatments for skin, respiratory, and other diseases. The company was founded in 2021 and is based in Shanghai, China. It raised approximately CNY 100 million in series A+ funding in October 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in